Show simple item record

dc.contributor.authorSingh, K
dc.contributor.authorGarg, G
dc.contributor.authorAli, V
dc.date.accessioned2019-10-21T00:32:00Z
dc.date.available2019-10-21T00:32:00Z
dc.date.issued2016
dc.identifier.issn1389-2002
dc.identifier.doi10.2174/1389200217666160819161444
dc.identifier.urihttp://hdl.handle.net/10072/388542
dc.description.abstractLeishmaniasis is one of the six diseases regarded most neglected by World Health Organization which is predominant in developing countries. Clinically, among the different forms of leishmaniasis, visceral leishmaniasis is the most fatal, serious disease, in which several organs of the body such as liver and spleen are affected. A limited number of drugs against leishmaniasis are available for the treatment and also, no suitable vaccine is available for the control of leishmaniasis. However, the drugs currently used for the treatment of leishmaniasis have serious side effects as well as drug resistance issues. Therefore, search for alternative drugs to treat leishmaniasis is widely pursued; often targeting the metabolic pathways of Leishmania which are either absent or different from the mammalian host and involved in survival, pathogenesis and drug resistance of parasite. Herein, we review the aspects of chemotherapy of leishmaniasis by synthetic and natural drugs, their mechanism of action, pharmacokinetics and involvement in the development of drug resistance. Furthermore, regulatory role of trypanothione as key molecule for redox homeostasis via antioxidant enzymes and proteins like tryparedoxin, tryparedoxin peroxidase, superoxide dismutase, and ascorbate peroxidase are presented. We have comprehensively discussed thiol metabolism as drug target and its role in parasite survival.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherBentham Science Publishers
dc.publisher.placeUnited Arab Emirates
dc.relation.ispartofpagefrom897
dc.relation.ispartofpageto919
dc.relation.ispartofissue9
dc.relation.ispartofjournalCurrent Drug Metabolism
dc.relation.ispartofvolume17
dc.subject.fieldofresearchPharmacology and Pharmaceutical Sciences
dc.subject.fieldofresearchcode1115
dc.titleCurrent therapeutics, their problems and thiol metabolism as potential drug targets in leishmaniasis
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationSingh, K; Garg, G; Ali, V, Current therapeutics, their problems and thiol metabolism as potential drug targets in leishmaniasis, Current Drug Metabolism, 2016, 17 (9), pp. 897-919
dcterms.dateAccepted2016-08-14
dc.date.updated2019-10-21T00:20:38Z
gro.hasfulltextNo Full Text
gro.griffith.authorSingh, Kuljit


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record